Biocon Ltd
SEC CIK 2036170 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BCAX | Bicara Therapeutics Inc. | 10% | 4.44M | — | — | 1 | 2024-09-16 | 2024-09-16 |
Most active insiders at BCAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | $4.80M | — |
| 2 | Cohlhepp Ryan | Pres, COO, Interim CEO, Dir | — | $4.60M |
| 3 | Mazumdar Claire | CEO, Dir | — | $4.06M |
| 4 | Hyep Ivan | CFO | — | $3.24M |
| 5 | Raben David | Chief Medical Off | — | $1.15M |
| 6 | Meisner Lara | CLO | — | $498.7K |
Biocon Ltd made no open-market trades at BCAX in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2024-09-16 | 2024-09-16 | BCAX | Bicara Therapeutics Inc. | Biocon Ltd | 10% | C - Cnv Deriv | $0.00 | +5.41M | 4.44M | New | $0 |
Purchase Sale Sale after option exercise All abbreviations